PERCEPTIVE ADVISORS LLC
Q4 2020 13F-HR Holdings
Net value change ($000)
+2,468,712
(36.0%)
New positions
38
Sold out positions
24
Turnover %
26.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Invitae Corp | 304,563 | NEW |
| Mirati Therapeutics, Inc. | 240,767 | 42.2% |
| Horizon Therapeutics Public Ltd Co | 225,597 | NEW |
| BBIO | 225,264 | 89.5% |
| FOLD | 225,114 | 63.5% |
| SpringWorks Therapeutics, Inc. | 137,022 | 82.6% |
| RCKT | 136,243 | 272.3% |
| AVIR | 129,903 | NEW |
| CCCC | 104,643 | NEW |
| TVTX | 95,218 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| MyoKardia, Inc. | -190,183 | -100.0% |
| CRSP | -112,187 | -100.0% |
| IMMUNOMEDICS INC | -77,559 | -100.0% |
| Global Blood Therapeutics, Inc. | -74,096 | -23.2% |
| BPMC | -61,606 | -100.0% |
| TVTX | -59,812 | -100.0% |
| Turning Point Therapeutics, Inc. | -28,819 | -100.0% |
| Molecular Templates, Inc. | -23,151 | -85.7% |
| PCVX | -19,388 | -46.2% |
| Forma Therapeutics Holdings, Inc. | -18,675 | -30.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
41,450
(0.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|